Literature DB >> 15282372

Genome-wide molecular dissection of serotype M3 group A Streptococcus strains causing two epidemics of invasive infections.

Stephen B Beres1, Gail L Sylva, Daniel E Sturdevant, Chanel N Granville, Mengyao Liu, Stacy M Ricklefs, Adeline R Whitney, Larye D Parkins, Nancy P Hoe, Gerald J Adams, Donald E Low, Frank R DeLeo, Allison McGeer, James M Musser.   

Abstract

Molecular factors that contribute to the emergence of new virulent bacterial subclones and epidemics are poorly understood. We hypothesized that analysis of a population-based strain sample of serotype M3 group A Streptococcus (GAS) recovered from patients with invasive infection by using genome-wide investigative methods would provide new insight into this fundamental infectious disease problem. Serotype M3 GAS strains (n = 255) cultured from patients in Ontario, Canada, over 11 years and representing two distinct infection peaks were studied. Genetic diversity was indexed by pulsed-field gel electrophoresis, DNA-DNA microarray, whole-genome PCR scanning, prophage genotyping, targeted gene sequencing, and single-nucleotide polymorphism genotyping. All variation in gene content was attributable to acquisition or loss of prophages, a molecular process that generated unique combinations of proven or putative virulence genes. Distinct serotype M3 genotypes experienced rapid population expansion and caused infections that differed significantly in character and severity. Molecular genetic analysis, combined with immunologic studies, implicated a 4-aa duplication in the extreme N terminus of M protein as a factor contributing to an epidemic wave of serotype M3 invasive infections. This finding has implications for GAS vaccine research. Genome-wide analysis of population-based strain samples cultured from clinically well defined patients is crucial for understanding the molecular events underlying bacterial epidemics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15282372      PMCID: PMC511060          DOI: 10.1073/pnas.0404163101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: clonal diversity and pyrogenic exotoxin expression.

Authors:  J M Musser; A R Hauser; M H Kim; P M Schlievert; K Nelson; R K Selander
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

2.  Size variation in group A streptococcal M protein is generated by homologous recombination between intragenic repeats.

Authors:  S K Hollingshead; V A Fischetti; J R Scott
Journal:  Mol Gen Genet       Date:  1987-05

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis.

Authors:  B Lei; F R DeLeo; N P Hoe; M R Graham; S M Mackie; R L Cole; M Liu; H R Hill; D E Low; M J Federle; J R Scott; J M Musser
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing.

Authors:  J M Musser; B M Gray; P M Schlievert; M E Pichichero
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

7.  Protective immunity to the group A Streptococcus may be only strain specific.

Authors:  S A de Malmanche; D R Martin
Journal:  Med Microbiol Immunol       Date:  1994-12       Impact factor: 3.402

8.  Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein.

Authors:  M P Harbaugh; A Podbielski; S Hügl; P P Cleary
Journal:  Mol Microbiol       Date:  1993-05       Impact factor: 3.501

9.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.

Authors:  J M Musser; V Kapur; J Szeto; X Pan; D S Swanson; D R Martin
Journal:  Infect Immun       Date:  1995-03       Impact factor: 3.441

10.  Streptococcal M protein size mutants occur at high frequency within a single strain.

Authors:  V A Fischetti; M Jarymowycz; K F Jones; J R Scott
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  65 in total

1.  Molecular genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen group A Streptococcus.

Authors:  Stephen B Beres; Ellen W Richter; Michal J Nagiec; Paul Sumby; Stephen F Porcella; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

2.  Mosaic prophages with horizontally acquired genes account for the emergence and diversification of the globally disseminated M1T1 clone of Streptococcus pyogenes.

Authors:  Ramy K Aziz; Robert A Edwards; William W Taylor; Donald E Low; Allison McGeer; Malak Kotb
Journal:  J Bacteriol       Date:  2005-05       Impact factor: 3.490

Review 3.  Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.

Authors:  James M Musser; Frank R DeLeo
Journal:  Am J Pathol       Date:  2005-12       Impact factor: 4.307

4.  Severe skin and soft tissue infections and associated critical illness.

Authors:  Donald C Vinh; John M Embil
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

5.  Emergence of a bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2.

Authors:  Izabela Sitkiewicz; Michal J Nagiec; Paul Sumby; Stephanie D Butler; Colette Cywes-Bentley; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

6.  The crystal structure of the streptococcal collagen-like protein 2 globular domain from invasive M3-type group A Streptococcus shows significant similarity to immunomodulatory HIV protein gp41.

Authors:  Flavia Squeglia; Beth Bachert; Alfonso De Simone; Slawomir Lukomski; Rita Berisio
Journal:  J Biol Chem       Date:  2013-12-19       Impact factor: 5.157

Review 7.  A decade of molecular pathogenomic analysis of group A Streptococcus.

Authors:  James M Musser; Samuel A Shelburne
Journal:  J Clin Invest       Date:  2009-09       Impact factor: 14.808

8.  Genome-wide analysis of ruminant Staphylococcus aureus reveals diversification of the core genome.

Authors:  Nouri L Ben Zakour; Daniel E Sturdevant; Sergine Even; Caitriona M Guinane; Corinne Barbey; Priscila D Alves; Marie-Françoise Cochet; Michel Gautier; Michael Otto; J Ross Fitzgerald; Yves Le Loir
Journal:  J Bacteriol       Date:  2008-06-20       Impact factor: 3.490

9.  Decreased necrotizing fasciitis capacity caused by a single nucleotide mutation that alters a multiple gene virulence axis.

Authors:  Randall J Olsen; Izabela Sitkiewicz; Ara A Ayeras; Vedia E Gonulal; Concepcion Cantu; Stephen B Beres; Nicole M Green; Benfang Lei; Tammy Humbird; Jamieson Greaver; Ellen Chang; Willie P Ragasa; Charles A Montgomery; Joiner Cartwright; Allison McGeer; Donald E Low; Adeline R Whitney; Philip T Cagle; Terry L Blasdel; Frank R DeLeo; James M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

10.  Clinical and epidemiological aspects of invasive Streptococcus pyogenes infections in Denmark during 2003 and 2004.

Authors:  Bogdan Luca-Harari; Kim Ekelund; Mark van der Linden; Margit Staum-Kaltoft; Anette M Hammerum; Aftab Jasir
Journal:  J Clin Microbiol       Date:  2007-10-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.